Faculty profile

Marco Leyton

ResearcherUniversité de Montréal

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université de Montréal directory, so their courses and email address may be missing. Find their university profile.

Marco Leyton

Researcher

Health Sciences

Université de Montréal

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
21 publications in the last five years, latest in 2026.
Senior (last) author on 8 recent papers, a sign of leading a research group.
Principal investigator on 1 research grant (1 CIHR), most recently in 2022.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Cannabis Longitudinal Cohort Neurocognition Neuroimaging Population Positron Emission Tomography Psychosis Risk

Latest papers

Reimagining the biopsychosocial model: hierarchical mechanisms from transdiagnostic to precision psychiatry.
Journal of psychiatry & neuroscience : JPN · 2026 · first author
Reimagining the Biopsychosocial Model: Transdiagnostic Factors to Precision Psychiatry.
Biological psychiatry global open science · 2026 · senior author
The mesocorticolimbic system in stimulant use disorder.
Molecular psychiatry · 2025

All 83 publications

Latest funding

Cannabis use-related harms on neurocognition and mental health: harnessing long-term longitudinal cohorts to study persistence, recovery, risk and resilience.
CIHR · 2026 · Co-investigator
$2,399,100
Longitudinal associations between cannabis and polysubstance use and neurocognition across youth (13-27 years): Evidence from two prospective birth cohorts
CIHR · 2022 · Co-investigator
$399,100
Ten-year Follow-up of the Montreal CoVenture Cohort on Cannabis and Psychosis Outcomes, Cognitive Functioning, and Synaptic Density: A Multimodal Neuroimaging Study with MRI and PET.
CIHR · 2022 · Principal investigator
$496,437

All 6 grants and awards

83 publications.

Reimagining the biopsychosocial model: hierarchical mechanisms from transdiagnostic to precision psychiatry.

Leyton M

Journal of psychiatry & neuroscience : JPN2026First author

DOI: 10.1139/jpn-2026-0063 PMID: 42599006

Reimagining the Biopsychosocial Model: Transdiagnostic Factors to Precision Psychiatry.

Nikolic M, Caswell CB, Prada NP, Iqbal M, Cox SML, Jaworska N, Castellanos-Ryan N, Vitaro F, Brendgen M, Parent S, Boivin M, Côté S, Tremblay RE, Séguin JR, Leyton M

Biological psychiatry global open science2026Senior author

DOI: 10.1016/j.bpsgos.2026.100734 PMID: 42293407

The mesocorticolimbic system in stimulant use disorder.

London ED, Groman SM, Leyton M, de Wit H

Molecular psychiatry2025

DOI: 10.1038/s41380-025-03148-0 PMID: 40926091

A multimodal neuroimaging study of youth at risk for substance use disorders: Functional magnetic resonance imaging and [18F]fallypride positron emission tomography.

Nikolic M, Cox SML, Jaworska N, Castellanos-Ryan N, Dagher A, Vitaro F, Brendgen M, Parent S, Boivin M, Côté S, Tremblay RE, Séguin JR, Leyton M

Alcohol, clinical & experimental research2025Senior author

DOI: 10.1111/acer.15511 PMID: 39725679

Resting-state alterations in emotion salience and default-mode network connectivity in atypical trajectories of psychotic-like experiences.

Assaf R, Ouellet J, Bourque J, Stip E, Leyton M, Conrod P, Potvin S

Development and psychopathology2025

DOI: 10.1017/s0954579424001317 PMID: 39297232

Experiences and barriers to alcohol use disorder treatment among adults with and without self-reported executive functioning challenges: A mixed-methods study.

Russell C, Wiese JL, Ruocco AC, Bozinoff N, Gonzalez R, Jennings S, Leyton M, Nikolova YS, Orson J, Potenza MN, Quilty LC, Shield KD, Verdejo-Garcia A, Wells S, Lange S, CDiA Program Study Group

Alcohol, clinical & experimental research2025

DOI: 10.1111/acer.70154 PMID: 40890992

Quantification of [11C]ABP688 Binding to mGluR5 in Human Brain using Cerebellum as Reference Region: Biological Interpretation and Limitations

Milella MS, Minuzzi L, Benkelfat C, Soucy J-P, Kirlow A, Schirrmacher E, Angle M, Verhaeghe JAJ, Massarweh G, Reader AJ

Current Neuropharmacology20252 citationsSenior author

DOI: 10.2174/1570159x23666250127161855

Testing PET-[ 11 C]ABP688 as a tool to quantify glutamate release in vivo.

Bdair H, Sato-Fitoussi M, Planche S, Moquin L, Kang MS, Aliaga A, Nagano-Saito A, Smart K, Cox SML, Near J, Aguilar-Valles A, Massarweh G, Rosa-Neto P, Benkelfat C, Soucy JP, Kostikov A, Gratton A, Leyton M

Imaging neuroscience (Cambridge, Mass.)2024Senior author

DOI: 10.1162/imag_a_00126 PMID: 40800322

Parameter Space and Potential for Biomarker Development in 25 Years of fMRI Drug Cue Reactivity: A Systematic Review.

Addiction Cue-Reactivity Initiative (ACRI) Network, Sangchooli A, Zare-Bidoky M, Fathi Jouzdani A, Schacht J, Bjork JM, Claus ED, Prisciandaro JJ, Wilson SJ, Wüstenberg T, Potvin S, Ahmadi P, Bach P, Baldacchino A, Beck A, Brady KT, Brewer JA, Childress AR, Courtney KE, Ebrahimi M, Filbey FM, Garavan H, Ghahremani DG, Goldstein RZ, Goudriaan AE, Grodin EN, Hanlon CA, Haugg A, Heilig M, Heinz A, Holczer A, Van Holst RJ, Joseph JE, Juliano AC, Kaufman MJ, Kiefer F, Khojasteh Zonoozi A, Kuplicki RT, Leyton M, London ED, Mackey S, McClernon FJ, Mellick WH, Morley K, Noori HR, Oghabian MA, Oliver JA, Owens M, Paulus MP, Perini I, Rafei P, Ray LA, Sinha R, Smolka MN, Soleimani G, Spanagel R, Steele VR, Tapert SF, Vollstädt-Klein S, Wetherill RR, Witkiewitz K, Yuan K, Zhang X, Verdejo-Garcia A, Potenza MN, Janes AC, Kober H, Zilverstand A, Ekhtiari H

JAMA psychiatry2024

DOI: 10.1001/jamapsychiatry.2023.5483 PMID: 38324323

Learning from opioid withdrawal: Effects on striatal dopamine (Commentary on Ahn et al., 2023).

Leyton M, Nikolic M

The European journal of neuroscience2024First author

DOI: 10.1111/ejn.16235 PMID: 38129315

Something wrong or missing on this profile? Suggest a correction

Marco Leyton

Research

Latest papers

Latest funding

Reimagining the biopsychosocial model: hierarchical mechanisms from transdiagnostic to precision psychiatry.

Reimagining the Biopsychosocial Model: Transdiagnostic Factors to Precision Psychiatry.

The mesocorticolimbic system in stimulant use disorder.

A multimodal neuroimaging study of youth at risk for substance use disorders: Functional magnetic resonance imaging and [18F]fallypride positron emission tomography.

Resting-state alterations in emotion salience and default-mode network connectivity in atypical trajectories of psychotic-like experiences.

Experiences and barriers to alcohol use disorder treatment among adults with and without self-reported executive functioning challenges: A mixed-methods study.

Quantification of [11C]ABP688 Binding to mGluR5 in Human Brain using Cerebellum as Reference Region: Biological Interpretation and Limitations

Testing PET-[ 11 C]ABP688 as a tool to quantify glutamate release in vivo.

Parameter Space and Potential for Biomarker Development in 25 Years of fMRI Drug Cue Reactivity: A Systematic Review.

Learning from opioid withdrawal: Effects on striatal dopamine (Commentary on Ahn et al., 2023).

Cannabis use-related harms on neurocognition and mental health: harnessing long-term longitudinal cohorts to study persistence, recovery, risk and resilience.

Longitudinal associations between cannabis and polysubstance use and neurocognition across youth (13-27 years): Evidence from two prospective birth cohorts

Ten-year Follow-up of the Montreal CoVenture Cohort on Cannabis and Psychosis Outcomes, Cognitive Functioning, and Synaptic Density: A Multimodal Neuroimaging Study with MRI and PET.

Temporal effects of alcohol and polysubstance use on neurocognition across youth (13-25 years): Evidence from a prospective birth cohort

Cannabis smoking and psychotic expériences in adolescents: A longitudinal brain Imaging study

Effects of delaying age of onset of binge drinking on adolescent brain development: A proposal to add neuroimaing measures to the CO-Venture Trial.

Frequent collaborators

Marco Leyton

Alain Dagher

Natalia Jaworska

Michel Boivin

Frank Vitaro

Natalie Castellanos Ryan

Natalie Castellanos Ryan

Sophie Parent

Pedro Rosa-Neto

Alexey Kostikov

Jean-Paul Soucy

Linda Booij

Linda Booij

Patricia Conrod

Linda Booij

Ridha Joober

Ridha Joober

Gabriella Gobbi

Cecilia Flores

Cecilia Flores

Josiane Bourque

Franco Lepore

Roberta La Piana

Yashar Zeighami

Argel Aguilar Valles

Julie Ottoy

Nikki Bozinoff

Myriam Srour

Samantha Wells

Caroline Brunelle